Publications by authors named "JF Smyth"

Claim this Profile
T
The use of real-world data in cancer drug development.
E Skovlund, H G M Leufkens, J F Smyth

Eur J Cancer· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Excellent translational research in oncology: A journey towards novel and more effective anti-cancer therapies.
A Rajan, A Berns, U Ringborg, J Celis, B Ponder, J F Smyth

Mol Oncol· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Actual developments in European regulatory and health technology assessment of new cancer drugs: what does this mean for oncology in Europe?
L Bergmann, H Enzmann, K Broich, A Hebborn, S Marsoni, J F Smyth

Ann Oncol· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinically relevant fatigue in men with hormone-sensitive prostate cancer on long-term androgen deprivation therapy.
D J Storey, D B McLaren, M A Atkinson, I Butcher, L C Frew, J F Smyth

Ann Oncol· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of galectin-3 expression with melanoma progression and prognosis.
Ewan R Brown, Tamasin Doig, Niall Anderson, Thomas Brenn, Val Doherty, John F Smyth

Eur J Cancer· April 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinically relevant fatigue in recurrence-free prostate cancer survivors.
D J Storey, D B McLaren, M A Atkinson, I Butcher, S Liggatt, J F Smyth

Ann Oncol· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A dynamic inflammatory cytokine network in the human ovarian cancer microenvironment.
Hagen Kulbe, Probir Chakravarty, D Andrew Leinster, Kellie A Charles, Joseph Kwong, John F Smyth

Cancer Res· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The interface between medical oncology and supportive and palliative cancer care.
Dawn J Storey, Marie T Fallon, John F Smyth

Semin Oncol· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Higher incidence of isolated brain metastases in ovarian cancer patients with previous early breast cancer.
Olusola O Faluyi, Charlie Gourley, John F Smyth, Dana Faratian, Alistair R Williams

Int J Gynecol Cancer· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
WWOX tumour suppressor gene polymorphisms and ovarian cancer pathology and prognosis.
Adam J W Paige, Manuela Zucknick, Szymon Janczar, Jim Paul, Charles A Mein, John F Smyth

Eur J Cancer· March 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The tumor-promoting actions of TNF-alpha involve TNFR1 and IL-17 in ovarian cancer in mice and humans.
Kellie A Charles, Hagen Kulbe, Robin Soper, Monica Escorcio-Correia, Toby Lawrence, John F Smyth

J Clin Invest· October 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
WWOX gene expression abolishes ovarian cancer tumorigenicity in vivo and decreases attachment to fibronectin via integrin alpha3.
Charlie Gourley, Adam J W Paige, Karen J Taylor, Carol Ward, Barbara Kuske, John F Smyth

Cancer Res· June 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
What to do after winning the Nobel Prize--work harder!
John F Smyth

Eur J Cancer· February 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Communication as important as cure.
John F Smyth

Eur J Cancer· January 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hormone therapy for epithelial ovarian cancer.
Simon P Langdon, John F Smyth

Curr Opin Oncol· September 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A clinical study assessing the tolerability and biological effects of infliximab, a TNF-alpha inhibitor, in patients with advanced cancer.
E R Brown, K A Charles, S A Hoare, R L Rye, D I Jodrell, J F Smyth

Ann Oncol· July 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Endometrioid epithelial ovarian cancer : 20 years of prospectively collected data from a single center.
Dawn J Storey, Robert Rush, Moira Stewart, Tzyvia Rye, Awatif Al-Nafussi, John F Smyth

Cancer· May 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I clinical and pharmacokinetic study of plitidepsin as a 1-hour weekly intravenous infusion in patients with advanced solid tumors.
Miguel A Izquierdo, Angela Bowman, Margarita García, Duncan Jodrell, Marisa Martinez, John F Smyth

Clin Cancer Res· May 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Disclosing gaps between supportive and palliative care: the past 20 years.
John F Smyth

Support Care Cancer· February 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The strength of European oncology.
John F Smyth

Eur J Cancer· January 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Validation of a new prognostic index for advanced epithelial ovarian cancer: results from its application to a UK-based cohort.
Taane G Clark, Moira Stewart, Tzyvia Rye, John F Smyth, Charlie Gourley

J Clin Oncol· December 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Estrogen-regulated gene expression predicts response to endocrine therapy in patients with ovarian cancer.
Graeme Walker, Kenneth MacLeod, Alistair R W Williams, David A Cameron, John F Smyth

Gynecol Oncol· September 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antiestrogen therapy is active in selected ovarian cancer cases: the use of letrozole in estrogen receptor-positive patients.
John F Smyth, Charlie Gourley, Graeme Walker, Melanie J MacKean, Alan Stevenson

Clin Cancer Res· June 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Insulin-like growth factor binding proteins IGFBP3, IGFBP4, and IGFBP5 predict endocrine responsiveness in patients with ovarian cancer.
Graeme Walker, Kenneth MacLeod, Alistair R W Williams, David A Cameron, John F Smyth

Clin Cancer Res· March 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sensitivity to pertuzumab (2C4) in ovarian cancer models: cross-talk with estrogen receptor signaling.
Peter Mullen, David A Cameron, Max Hasmann, John F Smyth, Simon P Langdon

Mol Cancer Ther· January 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis